DGAP-News: Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020


 

DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Corporate Action
Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020

30.07.2020 / 16:00
The issuer is solely responsible for the content of this announcement.


Press release

Eckert & Ziegler: Implementation of the share split by issuing bonus shares to be effective on 4 August 2020

Berlin, 30 July 2020. Eckert & Ziegler AG (ISIN DE0005659700, TecDAX) announces that the increase in share capital approved by the Annual General Meeting on 10 June 2020 has been registered in the commercial register and that the share split can now be implemented.

The Annual General Meeting on 10 June 2020 resolved to increase the share capital from currently EUR 5,292,983.00 by EUR 15,878,949.00 to EUR 21,171,932.00 from company funds. The capital increase was carried out by converting a partial amount of EUR 15,878,949.00 of the other revenue reserves reported under revenue reserves in the Company's annual balance sheet as of 31 December 2019 into share capital in return for the issue of 15,878,949 new no-par value bearer shares ("bonus shares"). The bonus shares are entitled to dividends from 1 January 2020. The Company's shareholders are entitled to the bonus shares on the basis of their shareholdings at a ratio of 1:3, so that for every one (1) existing share, the shareholders receive an additional three (3) bonus shares.

As all shares of the Company are held in collective giro accounts, the shareholders of the Company will receive co-ownership of the global certificate deposited with Clearstream Banking AG in the amount of the bonus shares attributable to them by means of a deposit credit and will not have to take any action in respect of the acceptance of these shares.

The bonus shares will be allocated to the entitled shareholders on the basis of their holdings of old shares according to the status as of 3 August 2020 after the close of the stock exchange by means of a deposit credit. The bonus shares will receive the same ISIN / WKN as the existing shares and will be included for trading on the regulated market of the Frankfurt Stock Exchange (Prime Standard).

About Eckert & Ziegler.
Eckert & Ziegler Eckert & Ziegler Strahlen- und Medizintechnik AG with more than 800 employees, is one of the world's largest providers of isotope-related components for radiation therapy and nuclear medicine. Eckert & Ziegler shares (ISIN DE0005659700) are listed in the TecDAX index of Deutsche Börse.
Contributing to saving lives.

Contact:
Eckert & Ziegler AG, Karolin Riehle, Investor Relations
Robert-Rössle-Str. 10, 13125 Berlin
Tel.: +49 (0) 30 / 94 10 84-138, [email protected], www.ezag.com



30.07.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Eckert & Ziegler Strahlen- und Medizintechnik AG
Robert-Rössle-Str.10
13125 Berlin
Germany
Phone: +49 30 941084-138
Fax: +49 30 941084-112
E-mail: [email protected]
Internet: www.ezag.de
ISIN: DE0005659700
WKN: 565970
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1106613

 
End of News DGAP News Service

1106613  30.07.2020 

fncls.ssp?fn=show_t_gif&application_id=1106613&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 138,63 168,71 178,49 176,14 180,44 222,26 246,09
EBITDA1,2 26,62 32,14 43,13 44,64 57,04 55,52 58,83
EBITDA-Marge3 19,20 19,05 24,16 25,34 31,61 24,98
EBIT1,4 17,97 23,39 32,06 33,69 47,45 44,54 45,45
EBIT-Marge5 12,96 13,86 17,96 19,13 26,30 20,04 18,47
Jahresüberschuss1 15,12 16,89 22,48 23,11 34,66 29,75 26,77
Netto-Marge6 10,91 10,01 12,59 13,12 19,21 13,39 10,88
Cashflow1,7 26,83 21,21 40,43 36,79 33,86 34,30 47,40
Ergebnis je Aktie8 0,70 0,78 1,07 1,11 1,66 1,41 1,26
Dividende8 0,20 0,30 0,42 0,45 0,50 0,50 0,17
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2022 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: Mazars

INVESTOR-INFORMATIONEN
©boersengefluester.de
Eckert & Ziegler
WKN Kurs in € Einschätzung Börsenwert in Mio. €
565970 37,220 Halten 788,02
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
23,26 26,33 0,89 40,95
KBV KCV KUV EV/EBITDA
3,56 16,63 3,20 12,87
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,50 0,05 0,13 28.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
14.05.2024 09.08.2024 14.11.2024 22.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
-10,57% 0,20% -9,88% -26,00%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Eckert & Ziegler Strahlen- und Medizintechnik AG  ISIN: DE0005659700 können Sie bei EQS abrufen


Medtech , 565970 , EUZ , XETR:EUZ